// App-Quantinova.ai

618 : Multiparametric magnetic resonance imaging can quantitatively assess fibroinflammatory response to direct acting antiviral treatment of hepatitis C virus.

Researchers

Presenter

  • Arjun N. Javaswal

Principal Investigators

  • Christina Levick

  • Michael Pavlides

  • Jane D. Collier

  • Stefan Neubauer

  • Eleanor Barnes

Medical Centers

  • Univ of Oxford Cntr for Clinical Magnetic Resonance Rsch, Univ of Oxford, Oxford, United Kingdom

  • Oxford University Hospitals NHS Trust, Oxford, United Kingdom

  • Peter Medawar Building, University of Oxford, Oxford, United Kingdom

  • Translational Gastroenterology Unit, University of Oxford, Oxford, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Gastroenterology (GU)

Disease

  • Hepatic fibrosis

  • Hepatitis C

  • Tuberculosis

  • Cirrhosis

Biomarkers

  • Alanine transaminase

  • Aspartate aminotransferase

  • Sustained virological response

  • Aspartate transaminase-platelet ratio index

  • Fibrosis-4

  • Iron‐corrected T1

Drug/Treatment

  • Desogestrel/ethinyl estradiol

Outcome

  • N/A


Study Design

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A